Our goal is to share our experiences of caring for pregnant and postpartum women with novel coronavirus disease 2019 (COVID-19) in New York, the COVID-19 epicenter in the United States and review current guidelines. We offer a guide, focusing on inpatient management, including testing ...
In March 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization of HCQ7and the number of prescriptions and usage outside clinical studies skyrocketed8. In many countries, HCQ or CQ were listed in treatment guidelines for COVID-19 (including, e.g., China, Irel...
The data were obtained from Optum’s longitudinal EHR repository, which includes data from more than 700 hospitals and 7000 clinics across the US and captures point-of-care diagnostic data that are specific to COVID-19, such as patient-level and clinical results from both inpatient and ...
Other studies also reported declining inpatient admissions during the COVID-19 pandemic16,24. These declines may be explained, in part, by a reduction in need. For example, decreased mobility and bans on alcohol sale in some places have led to fewer accidents and a lower need for trauma ...
First, at a median follow-up of 16 days, CLL patients with symptomatic COVID-19 have a high mortality rate when requiring inpatient admission (37%). Further, 49 patients who were admitted remain as inpatients at the time of analysis, suggesting that case fatality rate for inpatients in this...
This cross-sectional study examines changes in hospital costs for inpatient stays of patients with COVID-19 across the US.
(NCT04575597) adults with COVID-19. Following an interim analysis, it was concluded that molnupiravir was unlikely to provide clinical benefit in hospitalized patients and the inpatient MOVe-IN study was discontinued98,99. At the time of hospitalization patients are usually in the later stages ...
29,30). Remdesivir has been studied in patients with COVID-19 in both the outpatient and inpatient settings. In the PINETREE study, a 3-day course of i.v. remdesivir among unvaccinated outpatients with COVID-19 at a high risk of disease progression reduced 28-day hospitalization or death ...
National guidance of diagnosis and treatment of COVID-19 in both inpatient and outpatients setting. https://medcare.behdasht.gov.ir/. Updated on 13 Dec 2020 (accessed on 19 Dec 2020). Google Scholar [18] R.T. Gandhi, J.B. Lynch, C. Del Rio Mild or Moderate Covid-19 N. Engl. J...
There is no concrete evidence, until today, on the effectiveness and safety of the treatment of COVID-19 patients. Medications administered in the inpatient or ICU settings are based on previous efficacy results in treating, malaria, rheumatoid arthritis, Middle East respiratory syndrome (MERS), ...